One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Venous thromboembolism risk stratification, sex-related differences in dual antiplatelet therapy, and new targets for antithrombotic treatment
doi : 10.1093/eurheartj/ehag280
Volume 47, Issue 16, 21 April 2026
Cost vs reward: comparing educational cost and incomes for cardiology careers in the United States and Europe
Limitations of current animal models in atherosclerosis: an integrative multiomics perspective
Klimt’s ‘medicine’: at the crossroads of fate, healing, and human progress
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
Dual antiplatelet therapy modulation strategies beyond standard of care: a promising path towards individualized antiplatelet treatment
Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis
Anticoagulation for cancer-associated venous thromboembolism: navigating between risks of recurrence and bleeding
Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers
Primary prophylaxis of venous thromboembolism in ambulatory patients with active cancer
Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trial
Fibrin clot lysis predicts anticoagulant-associated bleeding in atrial fibrillation: ready for clinical use?
Controlling thrombosis without bleeding: a challenging concept that gathers pace
Targeting P2Y14R alleviates platelet-induced NET formation and venous thrombosis through PKA/AKAP13/RhoA axis
(Dis)solving the inflammatory neutrophil extracellular traps of venous thromboembolism with P2Y14 antagonists
Left-sided prosthetic valve thrombosis in low-income settings: why one size does not fit all
Low-dose, slow-infusion tPA is the treatment of choice for left-sided PVT
From myocarditis to arrhythmogenic right ventricular cardiomyopathy: a diagnostic odyssey in a young male with recurrent chest symptoms
Weekly Journal Scan: Complete revascularization in acute myocardial infarction improves major cardiovascular outcomes
